Lazard Asset Management
COLL icon

Lazard Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Lazard Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,222
Closed -$376K – 2097
2023
Q4 		$376K Buy
+12,222
New +$306K ﹤0.01% 1192
2023
Q1 		– Sell
-2,851
Closed -$66K – 2334
2022
Q4 		$66K Sell
2,851
-37,312
-93% -$752K ﹤0.01% 1680
2022
Q3 		$643K Buy
40,163
+8,858
+28% +$156K ﹤0.01% 1056
2022
Q2 		$554K Buy
31,305
+14,797
+90% +$249K ﹤0.01% 1093
2022
Q1 		$336K Sell
16,508
-4,427
-21% -$83.6K ﹤0.01% 1169
2021
Q4 		$391K Buy
+20,935
New +$408K ﹤0.01% 1148
2021
Q3 		– Sell
-2,811
Closed -$66K – 2170
2021
Q2 		$66K Sell
2,811
-7,664
-73% -$177K ﹤0.01% 1487
2021
Q1 		$248K Sell
10,475
-25,646
-71% -$609K ﹤0.01% 1071
2020
Q4 		$723K Buy
36,121
+3,946
+12% +$77K ﹤0.01% 934
2020
Q3 		$669K Sell
32,175
-15,236
-32% -$275K ﹤0.01% 845
2020
Q2 		$829K Buy
+47,411
New +$928K ﹤0.01% 777
2018
Q3 		– Sell
-8,405
Closed -$200K – 1057
2018
Q2 		$200K Hold
8,405
– – ﹤0.01% 847
2018
Q1 		$214K Buy
+8,405
New +$200K ﹤0.01% 836

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management's COLL Position: Q1 2024 in Review

Lazard Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2024, closing a stake of 12,222 shares — an estimated $376K sold.

Lazard Asset Management first reported a position in COLL in Q1 2018 and held it in 13 quarters. The position peaked at $829K in Q2 2020. 228 funds tracked by Wall St. Rank hold COLL as of Q1 2024.

  • Lazard Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Lazard Asset Management sold 12,222 Collegium Pharmaceutical shares in Q1 2024, an estimated $376K.
  • Lazard Asset Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 13 quarters.
  • Lazard Asset Management's Collegium Pharmaceutical position peaked at $829K in Q2 2020.
  • 228 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.